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Abstract
The processing and MHC class I-restricted presentation of antigenic peptides derived from the p60 protein of the facultative
intracellular bacterium Listeria monocytogenes is tightly linked to bacterial protein synthesis. We used non-linear regression
analysis to fit a mathematical model of bacterial antigen processing to a published experimental data set showing the
accumulation and decay of p60-derived antigenic peptides in L. monocytogenes-infected cells. Two alternative models
equally describe the experimental data. The simulation accounting for a stable and a hypothetical rapidly degraded form of
antigen predicts that the antigenic peptides p60 217–225 and p60 449–457 are derived from a putative instable form of p60
with an average intracellular half-life of approximately 3 minutes accounting for approximately 31% of all p60 molecules
synthesized. The alternative model predicts that both antigenic peptides are processed from p60 degraded intracellularly
with a half-life of 109 min and that antigen processing only occurs as long as bacterial protein synthesis is not inhibited. In
order to decide between both models the intracellular accumulation of p60 in infected cells was studied experimentally and
compared with model predictions. Inhibition of p60 degradation by the proteasome inhibitor epoxomicin revealed that
during the first 3 h post infection approximately 30% of synthesized p60 molecules were degraded. This value is
significantly lower than the approximately 50% degradation of p60 that would be expected in the presence of the predicted
putative short-lived state of p60 and also fits precisely with the predictions of the alternative model, indicating that the tight
connection of bacterial protein biosynthesis and antigen processing and presentation of L. monocyctogenes-derived
antigenic peptides is not caused by the presence of a highly instable antigenic substrate.
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Introduction
The immune surveillance by cytotoxic CD8 T cells of cells
infected by intracellular pathogens depends on the rapid
presentation of pathogen-derived antigenic peptides in the context
of MHC class I molecules on the surface of infected cells. The
proteasome degrades pathogen-derived proteins and generates
antigenic peptides that subsequently are transported into the
endoplasmatic reticulum were binding to nascent MHC class I
molecules occurs [1]. In eukaryotic cells proteins are degraded
with largely different kinetics. Remarkably, also individual proteins
are degraded intracellularly with different half-lifes. Approximate-
ly 30% of a newly synthesized protein enters the pool of rapidly
degraded proteins (RDP) which are degraded in less than 10 min.
The remainder protein enters the pool of slowly degraded proteins
which exhibit a much longer half-life [2,3,4,5].
A number of studies performed with virally infected cells suggest
that RDP provide the majority of antigenic peptides that are
transported by the transporters associated with antigen presentation
(TAP) and presented inthe context of MHCclass I molecules on the
surface of infected cells [5,6,7]. As RDP are rapidly degraded they
don’t accumulate intracellularly and thus blockade of protein
synthesis would rapidly deprive their intracellular pool. Therefore
the tight linkage of protein synthesis with antigen presentation can
be interpreted as experimental evidence for the dependency of
antigen presentation on RDP [8,9]. It was proposed that rapid
degradation of a protein is caused by errors in transcription,
translation or folding. For these rapidly degraded proteins the term
defective ribosomal products was introduced [10].
Studies by the Pamer laboratory revealed that the processing of
two antigenic peptides, p60 217–225 and p60 449–457 derived
from the p60 protein of the facultative intracellular bacterium
Listeria monocytogenes is tightly connected to de novo p60 protein
synthesis [11,12]. During infection of cells with L. monocytogenes p60
accumulates and is intracellularly degraded with a rather slow
half-life of approximately 90 min. Nevertheless, inhibition of
bacterial protein synthesis promptly abrogates antigen processing.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33335In contrast to viral pathogens, bacteria provide their own
protein biosynthesis apparatus. It is not known if in analogy to
cellular RDP inside cells also a fraction of bacterial proteins is
rapidly degraded.
In the current study the accumulation and decay of p60 in L.
monocytogenes-infected cells was studied in order to decide whether
putative p60-RDP are a major substrate for the processing of p60-
derived antigenic peptides. Mathematical modelling of p60
accumulation and degradation predicted that approximately
31% of synthesized p60 is rapidly degraded with a short half-life
of less than 5 min. These putative p60-RDP, however, were not
detected experimentally, indicating that the tight linkage of
bacterial antigen presentation is not caused by the presence of
an intracellular pool of highly instable p60 molecules.
Results
Modelling of p60 antigen processing predicts an instable
form of p60 as antigenic substrate
We used mathematical modelling in order to infer the
intracellular half-life and the relative amount of the putative
antigenic substrates from which p60 217–225 and p60 449–457
are processed from published experimental data. The data set used
was published by Sijts and Pamer [11] and shows the
accumulation of antigenic peptides in L. monocytogenes-infected cells
as well as the subsequent decay of accumulated peptide/MHC
complexes after inhibition of bacterial protein synthesis by
tetracycline added at 4h after infection of cells.
The processing of p60-derived antigenic peptides was either
simulated with hypothetical p60-RPD in addition to a slowly
degraded form of p60, or alternatively only with a single form of
p60.
In order to simulate the synthesis and the decay of putative p60-
RDP the previously described antigen processing and presentation
model [13] was expanded to represent two different states of an
antigenic substrate which decay with individual intracellular half-
life. Curve fitting to experimental data was performed by non-
linear step-wise regression analysis with the following parameters:
initial number o bacteria per cell: 1.25, bacterial doubling time:
60 min, bacterial p60 synthesis rate: 58 molecules/min/bacteri-
um, p60 217–225 processing efficacy 1 peptide per 35 degraded
p60 molecules, p60 217–225 half-life: 300 min. p60 449–457
processing efficacy 1 peptide per 1.7 degraded p60 molecules, p60
449–457 half-life: 60 min [11,13].
Fitting of the model to the p60 217–225 data set predicted an
instable antigenic substrate (half-life 2.2 min) accounting for
28.8% of the total amount of p60 synthesized and a highly stable
form of p60 with a half-life of .300 h (Fig. 1B). Fitting of the p60
449–457 data set predicted an instable antigenic substrate (half-life
4.7 min) accounting for 34.2% of the total amount of p60
synthesized and a highly stable form of p60 with a half-life of
.300 h (Fig. 1C). The coefficients of determination (R
2) for the
p60 217–225 and p60 449–457 datasets were 0.95 and 0.98,
respectively.
The above model accounts the p60 449–457 processing efficacy
with one peptide per 1.7 p60 molecules degraded [13]. If the
model is fitted with the maximum theoretical processing efficacy of
one p60 449–457 peptide per one degraded p60 molecule a p60-
RDP rate of 20.1% is predicted.
Alternatively, curve fitting was performed without p60-RDP
(only a single form of antigenic substrate) but assuming that after
inhibition of bacterial protein synthesis by tetracycline further
antigen processing and presentation is blocked. For the p60 217–
225 (Fig. 1D) and the p60 449–457 (Fig. 1E) data sets the model
predicts a p60 half-life of 106.6 min (R
2=0.92) and 111.8 min
(R
2=0.95), respectively.
Thus, taken together, both models quite precisely (R
2.0.9)
simulate the experimental datasets. The first model assuming the
presence of p60-RDP predicts an average of 31.5% p60-RDP with
a mean half-life of 3.4 min, whereas the alternative model without
p60-RDP assuming the blockade of antigen processing and
presentation after inhibition of bacterial protein synthesis predicts
an average p60 half-life of 109 min.
Quantitative analysis of p60 degradation in L.
monocytogenes-infected cells
In order to decide between the two antigen processing models
described above the possible presence of p60-RDP in infected cells
was investigated. In order to detect putative p60-RDP we
quantified the percentage of intracellularly degraded p60 in
infected cells by western blotting in the presence or absence of the
proteasome inhibitor epoxomicin. The absolute amount of p60 in
infected cells was determined by quantitative p60 western blot
analysis and subsequent interpolation with an external, serially
diluted p60 standard. The p60 standard was linear in the range
between 0.1 and 2 ng per sample and allowed to measure p60
levels in batches of infected cells between 2 and 4 h post infection
(Fig. 2 A–B).
In the presence of epoxomicin compared to untreated controls
significantly (p,0.05) more p60 was detected in lysates of L.
monocytogenes-infected cells between 2 and 4 h post infection
(Figure 2A, C). From the amount of p60 in the absence and
presence of epoxomicin, the percentage of degraded p60 was
calculated (Fig. 2D). The percentage of degraded p60 showed no
clear trend over time, therefore an average over all five time points
was calculated which was 33% (Fig. 2D).
Modelling of p60 accumulation in infected cells
Inhibition of intracellular p60 degradation revealed that
between 2 and 4 h post infection approximately 33% of all p60
molecules were degraded intracellularly. Again we used mathe-
matical modelling of p60 antigen processing to decide whether this
number is compatible with the hypothesis that putative p60-RDP
play a major role as a substrate of the processing of p60-derived
antigenic peptides. As prerequisite for these calculations the
intracellular half-life of p60 was determined experimentally. For
that purpose the decay of p60 was monitored in infected cells after
inhibition of bacterial protein-synthesis by addition of tetracycline
3 h post infection (Fig. 3). From the intracellular decay kinetics of
p60 the average half-life of intracellularly accumulated p60 was
calculated as 106 min (Fig. 3 A and D). No intracellular
degradation of p60 occurred in the presence of the proteasome
inhibitor epoxomicin (Fig. 3 B and D). At the time point when
tetracycline was added, 3 h post infection, significantly (34%,
p,0.05) less p60 was recovered from untreated cells compared to
epoxomicin-treated cells (Fig. 3 D) thus corroborating the results
from figure 2.
Using equation 9 from appendix S1 the accumulation of p60 in
infected cells was simulated. In order to estimate the effect of the
presence of p60-RDP on the intracellular kinetics of p60 the
simulation was performed without p60-RDP using the experi-
mentally determined p60 half-life of 106 min and also with 20%
and 31.5% of p60-RDP respectively. For p60-RDP the predicted
half-life of 3.4 min was used and for the remaining p60 fraction a
half-life of 106 min was accounted. As shown in figure 4 the model
clearly predicts that the presence of p60-RDP results in delayed
accumulation of intracellular p60 due to a higher percentage of
intracellularly degraded p60 molecules.
Presentation of Bacterial Antigens
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33335Figure 1. Mathematical modelling of p60 antigen processing. A. The interdependency of bacterial replication, antigen synthesis, antigen
decay, processing of antigenic peptides, and the decay of peptide/MHC complexes is represented as a system of ordinary differential equations. The
model assumes the existence of two states of an antigen that are synthesized with individual rates a1 and a2 and decay with different intracellular
half-life ta1 and ta2. The differential equations were solved for distinct physiological scenarios defined by the bacterial doubling time tg, the antigen
synthesis rate a, and the antigen half-life ta (see supporting information: appendix S1). B–E. In order to model infected cells that were treated with
tetracycline after 4 h of active bacterial replication the appropriate equations for t,4 h and t.4 h were merged to yield a stepwise function. This
stepwise function was fitted to experimental data by non-linear regression analysis. Experimental data (filled circles) of the numbers of p60217–225 (B,
D) and p60449–457 (C, E) peptides per cell at different time points after infection of cells with L. monocytogenes were taken from Sijts and Pamer 1997
[11]. In the experimental protocol after an initial period of 4 h of unrestricted bacterial replication and protein synthesis protein translation was
inhibited by addition of tetracycline. Curve fitting was either performed on the basis of the above model assuming the presence of p60-RDP and
assuming that previously accumulated p60 molecules are further processed and presented after inhibition of bacterial protein synthesis by
tetracycline (B, C). Alternatively curve fitting was performed with a model without p60-RDP assuming that after inhibition of bacterial protein
synthesis by tetracycline further antigen processing and presentation is blocked (D, E). Indicated are the results of curve fitting: the percentage of
short-lived p60 molecules (p60-RDP) and the half-lifes of short-lived p60-RDP (ta1) and long-lived p60 (ta2), and the coefficient of determination (R
2)o f
the curve fitting.
doi:10.1371/journal.pone.0033335.g001
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the percentage of p60 molecules degraded within the first 2, 3 and
4 h after infection of cells was calculated (Table 1). Considering an
average p60-RDP rate of 31.5% the model predicts that between
46.1% and 52.1% (average 49.4%) of p60 molecules are degraded,
compared to an average of 29% degraded p60 in the absence of
RDP. Thus the experimentally determined amount of 33%
intracellularly degraded p60 is most precisely predicted by the
model without p60-RDP.
We also calculated the absolute number of degraded p60
molecules in the absence and presence of p60-RDP and compared
the predicted values with the experimentally determined amount
of degraded p60 (Table 2). From the data shown in figure 2, i.e.
the amount of p60 and the percentage of decayed p60 molecules
the number per cell of decayed p60 molecules was calculated
(Table 2). Two, three, and four h after infection, 4678, 14527, and
26854 p60 molecules decayed per cell. The comparison of the
experimentally determined numbers with the model calculations
shows that the experimentally determined number of decayed p60
molecules per cell correlates most precisely with the predictions
from the model without p60-RDP (Table 2). For all time points the
predicted values were within the experimentally determined range
(mean+/2standard deviation).
Discussion
The current analysis suggests that the experimentally observed
tight linkage of bacterial protein synthesis and the presentation of
L. monocytogenes-derived CD8 T cell epitopes is not caused by the
presence of a highly instable antigenic substrate.
This conclusion is based on the assumption that the kinetics of
antigen presentation by infected cells depends on the expression
kinetics and half-life of the antigenic substrate. Based on this
assumption the intracellular decay of p60 was predicted from the
kinetics of the presentation of two p60-derived antigenic peptides.
Figure 2. Degradation of p60 in infected cells. Cells were infected with L. monocytogenes in the presence (+EPOX) or absence (Ø EPOX) of the
proteasome inhibitor epoxomicin. At the indicated time points post infection cells were harvested and intracellular p60 was detected by western
blotting. Shown is a representative western blot (A). The absolute amount of p60 was quantified by interpolation with an external p60 standard (B).
From the total amount of p60 in the presence and absence of epoxomicin (C) the percentage of degraded p60 was calculated (D). The broken line
indicates the average percentage of degraded p60 calculated over all five time points (33%). Shown are the means and standard deviations of four
independent experiments. Asterisks (*) indicate a statistical significant (p,0.05) difference between matched values of both experimental groups.
doi:10.1371/journal.pone.0033335.g002
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RDP to experimental data predicts that antigen presentation solely
depends on the degradation of a fraction of 31.5% p60-RDP
decaying intracellular with an average half-life of 3.4 min while for
the remaining p60 a half-life of .300 h was predicted. The very
short half-life of p60-RDP elegantly explains the tight connection
between p60 synthesis and the presentation of p60-derived
antigenic peptides without requiring further assumptions [8,9].
Obviously, the prediction of an almost inert p60 pool
contradicts the experimentally determined intracellular p60 half-
life of 90 [12] to 109 min (our data). In regard to antigen
presentation, however, the predicted very long half-life has to be
interpreted as a p60 pool that does not play a role as substrate for
antigen processing and presentation. Because degradation it is not
linked to antigen presentation the real intracellular half-life of this
pool can not be inferred from the amount of p60-derived antigenic
peptides. Thus the interpretation is that the remaining p60 is
degraded intracellularly with a half-life of approximately 106 min
without generating p60-derived antigenic peptides.
Fitting of the alternative antigen processing model, without p60-
RDP predicts that all p60 molecules decay intracellularly with a
half-life of 109 min, a prediction which very precisely fits the
experimentally measured value of 106 min. This model, however,
requires the additional assumption that antigen presentation is
somehow linked to bacterial protein synthesis because it does not
explain why previously accumulated p60 molecules [13] that after
inhibition of bacterial protein synthesis decay with an intracellular
half-life of 106 min are not a substrate for the processing of p60-
derived antigenic peptides.
Radio-labelling of infected cells for p60 quantification was not
used in the current study as the pulsing of cells with radio-labelled
amino acids in nutrient-deficient culture medium might shift cells
to a catabolic state that influences physiologic cellular protein
turnover rates [14]. The p60 half-life determined without radio-
labelling (106 min.), however was in the same range as the value of
90 min determined by radio-labelling [12], indicating that this
effect had only a minor impact.
In contrast to virus-derived antigenic peptides that are
generated with an efficacy of 1 antigenic peptide per several
thousand degraded antigens [7,15] the L. monocytogenes p60-derived
antigenic peptides p60 217–225 and in p60 449–457 are generated
with much higher efficacies of 1 antigenic peptide per 35 and 1 per
1.7 degraded p60 molecules, respectively [11,12,13,16]. Thus in
contrast to viral antigenic peptides a very high percentage of an
antigen has to be degraded in order to generate sufficient antigenic
peptides for antigen presentation.
Both, p60 degradation as well as antigen presentation of p60
217–225 and p60 449–457 are inhibited by proteasome inhibitors
[17,18]. Also after inhibition of bacterial protein synthesis the pool
of accumulated p60 molecules is inhibited by proteasome
inhibitors, thus linking the degradation of this p60 pool to the
proteasome. An important requirement for our experimental
approach for the detection of putative p60-RDP is the inhibition of
p60 degradation without inhibiting bacterial replication or
bacterial protein synthesis. Inhibition of bacterial protein synthesis
would result in lower protein levels and such strongly influence the
calculation of degraded antigens. We used epoxomicin for all
proteasome inhibition experiments because it has the least effect
on bacterial replication and p60 synthesis among a panel of
various proteasome inhibitors [17].
It is currently unknown, however, why the proteasome-
mediated degradation of accumulated p60 molecules does not
yield antigenic peptides that are presented in the context of MHC
class I molecules [11,12]. Without the tight linkage to bacterial
protein synthesis the presentation of p60-derived antigens should
continue after antibiotic inhibition of protein synthesis because a
few hours after infection the accumulated p60 molecules could
provide antigenic peptides for several hours [13].
It has previously been shown that intracellular Salmonella are
recognized by the ubiquitin system resulting in spatial association
of proteasomes and intracellular bacteria [19], providing a possible
direct link between bacteria, bacterial protein translation, and
antigen presentation. Listeria monocytogenes, however, evades recog-
nition by the ubiquitin system by actin-based motility thus
escaping the potential direct association with proteasomes [19].
Triggering of the functional state of the proteasome by the
biochemical activity of the bacteria, e.g. by intracellular motility or
Figure 3. Half-life of p60 in L. monocytogenes-infected cells.
Three hours after infection further bacterial protein synthesis was
inhibited by tetracycline treatment of cells and intracellular p60 was
detected by western blot at the indicated time points either in the
absence (A) or presence (B) of epoxomicin as shown in the schematic
drawing (C). By interpolation with an external p60 standard the total
amount of p60 per 100.000 cells was calculated in the presence (+EPOX)
or absence (Ø EPOX) of epoxomicin (D). Shown are the means and
standard deviations of three independent experiments.
doi:10.1371/journal.pone.0033335.g003
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processing and de novo protein synthesis. A possible trigger could
be provided by viability-associated pathogen-associated molecular
patterns such as bacterial messenger RNA which elicits a unique
innate response [20]. The association of freshly synthesized
unfolded p60 molecules with a cellular chaperone that marks the
p60 for later processing by the proteasome [21,22] or directing of a
fraction of newly synthesized p60 to a hypothetical specialized
antigen processing compartment [23] seems unlikely as these
processes would continue after inhibition of bacterial protein
synthesis, which is not supported by the experimental evidence.
Taken together our data strongly suggest that the tight linkage
of p60 protein synthesis by L. monocytogenes and the processing of
p60-derived antigenic peptides is independent of putative p60-
RDPs.
Materials and Methods
Bacteria and cell lines
All in vitro infections were performed with L monocytogenes 43251
[12]. Bacteria were grown at 37uC in brain heart infusion bouillon
(BD, Heidelberg, Germany) and used for infection in the
logarithmic growth phase. The bacterial concentration was
estimated from the OD at 600 nm. The macrophage-like
J774A.1 (J774) cell line was purchased from the American Type
Culture Collection (Manassas, VA) and was grown in DMEM
(Invitrogen, Karlsruhe, Germany) cell growth medium containing
10% FCS (PAA, Pasching, Austria).
Reagents
The irreversible proteasome inhibitor epoxomicin (SIGMA,
Deisenhofen, Germany) was used at concentrations of 2 mM.
Epoxomicin was dissolved in dimethyl sulfoxide to yield a 10006
stock solution and stored at 280uC until use. Complete protease
inhibitor cocktail tablets were from Roche (Mannheim, Germany)
und used according to the suggestions of the manufacturer.
DNAse and RNAse were purchased from SIGMA (Deisenhofen,
Germany). Tetracyclin (SIGMA) was dissolved in methanol to
yield a 5006stock solution (10 mg/ml) stored at 220uC until use.
Figure 4. Mathematical modelling of p60 accumulation in infected cells. The intracellular accumulation of p60 was modeled in the absence
of p60-RDP using the experimentally determined p60 half-life of 106 min (Ø RDP) or under the assumption that 20% or 31.5% of p60 is rapidly
degraded with the predicted half-life of 3.4 min whereas the remaining p60 fraction decays with a half-life of 106 min. In addition the accumulation
of p60 was modeled without p60 decay (solid line). For the calculations equation 9 from appendix S1 was used. The initial number o bacteria per cell
was 1.25, bacterial doubling time: 60 min, total bacterial p60 synthesis rate 58 molecules/min/bacterium.
doi:10.1371/journal.pone.0033335.g004
Table 1. Predicted p60 decay in the presence and absence of
p60-RDP.
p60-RDP
1
h post none 20% 31.5%
infection predicted p60 decay [%]
2 h 24.6 38.2 46.1
3 h 29.8 42.6 50.0
4 h 32.7 45.1 52.1
average 29.0 42.0 49.4
1calculations with RDP were performed on the basis of the predicted p60-RDP
half-life of 3.4 min, for the calculation without RDP a p60 half-life of 106 min
was used.
doi:10.1371/journal.pone.0033335.t001
Table 2. Stoichiometry of p60 in L. monocytogens-infected
cells.
decayed p60
prediction
1 experiment
2
p60-RDP
h post none 31.5% mean SD
infection [p60 molecules per cell] [p60 molecules per cell]
2 h 4626 8675 4678 6879
3 h 13106 21967 14527 64326
4 h 30851 49090 26854 622525
1calculations with RDP were performed on the basis of the predicted p60-RDP
half-life of 3.4 min, for the calculation without RDP a p60 half-life of 106 min
was used.
2Means and standard deviations (SD) calculated from 4 experiments.
doi:10.1371/journal.pone.0033335.t002
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J774 cells were grown to 70% confluence in 6 cm cell culture
dishes in 4 ml DMEM supplemented with 10% FCS without
antibiotics. Cells were infected for 30 min with 0.4 ml of a log
phase culture of L. monocytogens (OD600=0.1). Infected cells were
washed twice with DMEM supplemented with 10% FCS and
cultured in DMEM with 10% FCS containing 15 mg/ml
gentamicin to inhibit extracellular bacterial growth.
Epoxomicin was added 30 min after infection to yield final
concentrations of 250 mM and 2 mM, respectively. Tetracycline
was added to a final concentration of 20 mg/ml.
At indicated time points cells were washed twice with PBS and
lysed in 300 ml of lysis buffer (16 TRIS-buffered saline, 0.1%
Triton X-100, Complete protease inhibitor, 50 U/ml DNAse,
50 U/ml RNAse). After 15 min at room temperature lysates were
cleared by centrifugation at 14.000 g for 10 min.
Cell lysates were prepared by heating in SDS-PAGE sample
buffer (BioRad, Mu ¨nchen, Germany) for 5 min.
Proteins were separated by SDS-PAGE (10% gel) and blotted
onto nitrocellulose (Schleicher & Schuell BioSciences, Dassel,
Germany). Blots were blocked in 5% (w/v) dry milk and probed
with a 1:1.000 dilution of a polyclonal rabbit anti-Listeria
moncytogenes p60 antibody (batch R2556) for 4 h and simultaneously
probed with rabbit anti-GAPDH and goat anti-GAPDH (abcam,
Cambridge, UK) as loading controls in dilutions of 1:2500 and
1:1000, respectively. Blots were developed with horseradish
peroxidase-conjugated anti-rabbit 1:5000; DAKOCytomation,
Glostrup, Denmark) and enhanced chemiluminescence (Pierce,
Rockford, USA). CCD imaging was performed with the LAS-1000
luminescent imaging system (Raytest). Quantification of the
amount of p60 of individual samples was performed by
interpolation with an external serially diluted p60 standard using
AIDA software (Raytest). In order to account for differences in
loading volume or protein extraction efficacies all samples were
normalized for GAPDH content.
The number of p60 molecules per cell was calculated as
moleculesp60=m p60[ng]/1*10
9/CE/Mp60*N A, with mp60[ng] the
total amount in ng of p60 in the sample, CE the number of cell
equivalents in the sample, Mp60 the molar mass of the secreted
truncated form of p60 (p60 28–484, M=4801 g/mol), and NA the
Avogadro constant (6.023610
23).
Statistical analysis
The statistical significance of the results was analyzed using the
t-test at the 0.05 significance level. Calculations were performed
using the WINKS statistical analysis software (TEXASOFT,
Cedar Hill, USA).
Computational simulation of antigen presentation of
bacterial antigen synthesis and non-linear regression
analysis
In order to model the kinetics of antigen degradation and the
formation of peptide/MHC complexes in antigen presenting cells,
we used a basic deterministic model [13] (Fig. 1A). Briefly, the
model describes the steps involved in antigen processing and
presentation by a few well-defined parameters, which can be
experimentally determined for a specific bacterial T cell antigen:
the bacterial replication rate defined by the bacterial doubling
time tg, the bacterial antigen production rate a, the antigen half-
life ta, the peptide processing efficacy x (defined as the ratio of
generated peptide/MHC complexes per degraded antigen), and
the half-life of the MHC/peptide complex tc. As in other
published models [24] the possible limitation of the formation of
peptide/MHC complexes by limited supply of nascent MHC class
I molecules was not accounted for in order to keep the model as
simple as possible [13]. All other peptides which are not protected
by complex formation with MHC molecules are rapidly degraded
[25].
The previous model was expanded to represent two different
states of antigen a1 and a2, with individual synthesis rates a1, a2
and individual intracellular half-life ta1, and ta2, respectively. Cells
infected with actively replicating bacteria were modeled by a
bacterial replication rate .0 and a bacterial protein synthesis rate
a=a1+a2.0. Antibiotic abridgement of infection by treatment
with tetracycline was simulated by an infinite bacterial doubling
time (tgR‘) and absent bacterial protein synthesis (a1=a2=0).
Cells treated with the proteasome inhibitor epoxomicin were
modeled by an infinite antigen half-life (taR‘). The derivation of
the formulas used is described in detail in the supporting
information (Appendix S1).
In order to simulate infected cells that were treated with
tetracycline after 4 h of active bacterial replication the appropriate
equations for t,4 h and t.4 h were merged to yield a stepwise
function. This stepwise function was fitted to experimental data by
non-linear regression analysis. Regression analysis was performed
using NLREG software (www.nlreg.com) running on a personal
computer.
Supporting Information
Appendix S1 Derivation of the formulas used for the modeling
of the processing and presentation of bacteria-derived antigenic
peptides.
(PDF)
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